(Q38110317)

29 August 2017

title

Review article: strategies for the management of chronic unremitting ulcerative colitis (English)

1 reference

29 August 2017

1 reference

S J Mehta

1

1 reference

29 August 2017

A R Silver

series ordinal

2

1 reference

29 August 2017

J O Lindsay

series ordinal

3

1 reference

29 August 2017

language of work or name

English

0 references

publication date

29 May 2013

1 reference

Alimentary Pharmacology & Therapeutics

29 August 2017

published in

1 reference

29 August 2017

volume

38

1 reference

29 August 2017

issue

2

1 reference

29 August 2017

page(s)

77-97

1 reference

Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review

29 August 2017

cites work

1 reference

Distribution and manifestations of inflammatory bowel disease in Asians, Hispanics, and African Americans: a systematic review

21 January 2018

1 reference

21 January 2018

1 reference

Questions on life satisfaction (FLZM) in inflammatory bowel disease

21 January 2018

1 reference

The impact of ulcerative colitis on patients' lives compared to other chronic diseases: a patient survey.

21 January 2018

1 reference

Systematic review: the costs of ulcerative colitis in Western countries

21 January 2018

1 reference

The risk of colorectal cancer in ulcerative colitis: a meta-analysis

21 January 2018

1 reference

Risk factors for ulcerative colitis-associated colorectal cancer in a Hungarian cohort of patients with ulcerative colitis: results of a population-based study

21 January 2018

1 reference

Long-term risk of cancer in ulcerative colitis: a population-based cohort study from Copenhagen County

21 January 2018

1 reference

Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis.

21 January 2018

1 reference

Clinical course of ulcerative colitis.

21 January 2018

1 reference

Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study).

21 January 2018

1 reference

Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease

21 January 2018

1 reference

Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort

21 January 2018

1 reference

Guidelines for the management of inflammatory bowel disease in adults

21 January 2018

1 reference

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management

21 January 2018

1 reference

American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease

21 January 2018

1 reference

Clostridium difficile and inflammatory bowel disease

21 January 2018

1 reference

Role of faecal calprotectin as non-invasive marker of intestinal inflammation.

21 January 2018

1 reference

Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse.

21 January 2018

1 reference

Cytomegalovirus colitis complicating inflammatory bowel disease

21 January 2018

1 reference

Cortisone in ulcerative colitis; final report on a therapeutic trial.

21 January 2018

1 reference

Review article: improving adherence to medication in patients with inflammatory bowel disease

21 January 2018

1 reference

Combined oral and enema treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis: a randomised, double blind, placebo controlled study

21 January 2018

1 reference

Out-patient treatment of ulcerative colitis. Comparison between three doses of oral prednisone.

21 January 2018

1 reference

Rectal corticosteroids versus alternative treatments in ulcerative colitis: a meta-analysis

21 January 2018

1 reference

Clinical trial: a novel high-dose 1 g mesalamine suppository (Salofalk) once daily is as efficacious as a 500-mg suppository thrice daily in active ulcerative proctitis

21 January 2018

1 reference

A Multicenter, Randomized Study to Evaluate the Efficacy and Safety of Mesalamine Suppositories 1 g at Bedtime and 500 mg Twice Daily in Patients with Active Mild-to-Moderate Ulcerative Proctitis

21 January 2018

1 reference

Comparison of mesalazine and balsalazide in induction and maintenance of remission in patients with ulcerative colitis: a meta-analysis

21 January 2018

1 reference

Use of mesalazine slow release suppositories 1 g three times per week to maintain remission of ulcerative proctitis: a randomised double blind placebo controlled multicentre study

21 January 2018

1 reference

Efficacy of 5-aminosalicylates in ulcerative colitis: systematic review and meta-analysis

21 January 2018

1 reference

Limited exposure of the healthy distal colon to orally-dosed formulation is further exaggerated in active left-sided ulcerative colitis.

21 January 2018

1 reference

Rectal tacrolimus in the treatment of resistant ulcerative proctitis

21 January 2018

1 reference

Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study.

21 January 2018

1 reference

Short chain fatty acid rectal irrigation for left-sided ulcerative colitis: a randomised, placebo controlled trial

21 January 2018

1 reference

Epidermal growth factor enemas with oral mesalamine for mild-to-moderate left-sided ulcerative colitis or proctitis

21 January 2018

1 reference

Distal ulcerative colitis refractory to rectal mesalamine: role of transdermal nicotine versus oral mesalamine

21 January 2018

1 reference

Nicotine tartrate liquid enemas for mildly to moderately active left-sided ulcerative colitis unresponsive to first-line therapy: a pilot study

21 January 2018

1 reference

Nicotine enemas for active ulcerative colitis--a pilot study

21 January 2018

1 reference

A randomised, controlled, double blind, escalating dose study of alicaforsen enema in active ulcerative colitis

21 January 2018

1 reference

Bioavailability and therapeutic activity of alicaforsen (ISIS 2302) administered as a rectal retention enema to subjects with active ulcerative colitis

21 January 2018

1 reference

Appendicectomy as a therapy for ulcerative proctitis.

21 January 2018

1 reference

Restorative proctocolectomy for distal ulcerative colitis

21 January 2018

1 reference

Delayed-release oral mesalamine at 4.8 g/day (800 mg tablet) for the treatment of moderately active ulcerative colitis: the ASCEND II trial

21 January 2018

1 reference

Once daily versus three times daily mesalazine granules in active ulcerative colitis: a double-blind, double-dummy, randomised, non-inferiority trial

21 January 2018

1 reference

Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study

21 January 2018

1 reference

Infliximab for induction and maintenance therapy for ulcerative colitis

21 January 2018

1 reference

Treatment of ulcerative colitis with adalimumab or infliximab: long-term follow-up of a single-centre cohort

21 January 2018

1 reference

Efficacy of intravenous cyclosporin in moderately severe ulcerative colitis refractory to steroids

21 January 2018

1 reference

A randomised dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis

21 January 2018

1 reference

Double-blind, placebo-controlled trial of oral tacrolimus (FK506) in the management of hospitalized patients with steroid-refractory ulcerative colitis

21 January 2018

1 reference

Short-term efficacy of tacrolimus in steroid-refractory ulcerative colitis - experience in 130 patients

21 January 2018

1 reference

Long-term effect of tacrolimus therapy in patients with refractory ulcerative colitis.

21 January 2018

1 reference

Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis

21 January 2018

1 reference

The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review

21 January 2018

1 reference

Randomised controlled trial of azathioprine withdrawal in ulcerative colitis

21 January 2018

1 reference

Thiopurine methyltransferase activity and the use of azathioprine in inflammatory bowel disease

21 January 2018

1 reference

Association of 6-thioguanine nucleotide levels and inflammatory bowel disease activity: a meta-analysis.

21 January 2018

1 reference

Clinical usefulness of therapeutic drug monitoring of thiopurines in patients with inadequately controlled inflammatory bowel disease.

21 January 2018

1 reference

Optimising outcome on thiopurines in inflammatory bowel disease by co-prescription of allopurinol.

21 January 2018

1 reference

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

21 January 2018

1 reference

Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease

21 January 2018

1 reference

Predictors of early response to infliximab in patients with ulcerative colitis.

21 January 2018

1 reference

A multicenter experience with infliximab for ulcerative colitis: outcomes and predictors of response, optimization, colectomy, and hospitalization

21 January 2018

1 reference

Disease activity, ANCA, and IL23R genotype status determine early response to infliximab in patients with ulcerative colitis

21 January 2018

1 reference

Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis

21 January 2018

1 reference

One-year maintenance outcomes among patients with moderately-to-severely active ulcerative colitis who responded to induction therapy with adalimumab: subgroup analyses from ULTRA 2.

21 January 2018

1 reference

Efficacy of methotrexate in Crohn's disease and ulcerative colitis patients unresponsive or intolerant to azathioprine /mercaptopurine

21 January 2018

1 reference

Efficacy of immunosuppressive therapy for inflammatory bowel disease: a systematic review and meta-analysis

21 January 2018

1 reference

Mycophenolate mofetil therapy for refractory inflammatory bowel disease

21 January 2018

1 reference

Leukocytapheresis in ulcerative colitis: results of a multicenter double-blind prospective case-control study with sham apheresis as placebo treatment.

21 January 2018

1 reference

Multicenter randomized controlled trial for the treatment of ulcerative colitis with a leukocytapheresis column

21 January 2018

1 reference

A randomized, double-blind, sham-controlled study of granulocyte/monocyte apheresis for active ulcerative colitis

21 January 2018

1 reference

Systematic review: granulocyte/monocyte adsorptive apheresis for ulcerative colitis

21 January 2018

1 reference

Treatment of ulcerative colitis with a humanized antibody to the alpha4beta7 integrin

21 January 2018

1 reference

Tofacitinib, an oral Janus kinase inhibitor, in active ulcerative colitis.

21 January 2018

1 reference

Ileal pouch anal anastomosis: analysis of outcome and quality of life in 3707 patients

21 January 2018

1 reference

Evaluation of long-term function, complications, quality of life and health status after restorative proctocolectomy with ileo neo rectal and with ileal pouch anal anastomosis for ulcerative colitis

21 January 2018

1 reference

Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades: a population-based study from Copenhagen, Denmark.

21 January 2018

1 reference

Social and sexual function following ileal pouch-anal anastomosis

21 January 2018

1 reference

Fertility after ileal pouch-anal anastomosis in women with ulcerative colitis

21 January 2018

1 reference

Fertility is reduced after restorative proctocolectomy with ileal pouch anal anastomosis: a study of 300 patients.

21 January 2018

1 reference

Colectomy with ileorectal anastomosis preserves female fertility in ulcerative colitis.

21 January 2018

1 reference

Surgery in ulcerative colitis: indication and timing

21 January 2018

1 reference

Long-term failure and function after restorative proctocolectomy - a multi-centre study of patients from the UK National Ileal Pouch Registry

21 January 2018

1 reference

Colectomy and the incidence of postsurgical complications among ulcerative colitis patients with private health insurance in the United States.

21 January 2018

1 reference

Corticosteroids but not infliximab increase short-term postoperative infectious complications in patients with ulcerative colitis

21 January 2018

1 reference

Effect of high-dose steroids on anastomotic complications after proctocolectomy with ileal pouch-anal anastomosis

21 January 2018

1 reference

Systematic review of postoperative complications in patients with inflammatory bowel disease treated with immunomodulators

21 January 2018

1 reference

Should ileoanal pouch surgery be staged for patients with mucosal ulcerative colitis on immunosuppressives?

21 January 2018

1 reference

Meta-analysis: pre-operative infliximab treatment and short-term post-operative complications in patients with ulcerative colitis

21 January 2018

1 reference

Preoperative biological therapy and short-term outcomes of abdominal surgery in patients with inflammatory bowel disease

21 January 2018

1 reference

Meta-analysis: effect of preoperative infliximab use on early postoperative complications in patients with ulcerative colitis undergoing abdominal surgery

21 January 2018

1 reference

Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/APT.12345

1 reference

release_kjaqba52gba7rmenccqrqk3jcq

29 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/kjaqba52gba7rmenccqrqk3jcq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference